Cologuard is an at-home stool DNA screening test prescribed by a clinician and processed by a lab to help screen for colorectal cancer in people at average ...

Memorial Health System continued its new monthly community health education series with a presentation by Dr. Allison ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

It's a rite of passage we don't look forward to: Once we turn 45, it's recommended that we get a colonoscopy to screen for ...

CLEVELAND — The Teal Wand detects high-risk types of Human Papillomavirus, the virus responsible for nearly all cervical cancers. Women can collect the sample at home and mail it to a lab for analysis ...

Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of developing blood testing kits for markets outside the U.S. The licensing ...

Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...

(Reuters) -Abbott will buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, marking one of its largest purchases in nearly a decade and a bold entry into the ...

ABBOTT PARK, Ill./MADISON, Wis. — Abbott Laboratories, headquartered in north suburban Abbott Park, will acquire Madison, Wisconsin-based Exact Sciences, the companies announced in a news release ...

TEXAS – A new wave of blood tests is changing how doctors detect cancer. These tests can find signs of cancer early, sometimes before symptoms appear, giving patients a better chance at successful ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...